Charles Schwab Investment Management Inc Sutro Biopharma, Inc. Transaction History
Charles Schwab Investment Management Inc
- $519 Billion
- Q2 2024
A detailed history of Charles Schwab Investment Management Inc transactions in Sutro Biopharma, Inc. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 216,828 shares of STRO stock, worth $758,898. This represents 0.0% of its overall portfolio holdings.
Number of Shares
216,828
Previous 160,876
34.78%
Holding current value
$758,898
Previous $908,000
30.07%
% of portfolio
0.0%
Previous 0.0%
Shares
16 transactions
Others Institutions Holding STRO
# of Institutions
124Shares Held
63MCall Options Held
200Put Options Held
27.6K-
Suvretta Capital Management, LLC New York, NY7.71MShares$27 Million0.94% of portfolio
-
Black Rock Inc. New York, NY6.91MShares$24.2 Million0.0% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct4.45MShares$15.6 Million0.04% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny4.36MShares$15.3 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.56MShares$12.4 Million0.0% of portfolio
About SUTRO BIOPHARMA, INC.
- Ticker STRO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 52,161,500
- Market Cap $183M
- Description
- Sutro Biopharma, Inc. operates as clinical stage drug discovery, development, and manufacturing company. It focuses on creating protein therapeutics for cancer and autoimmune disorders through integrated cell-free protein synthesis and site-specific conjugation platform, XpressCF+.The company's product candidates include STRO-001, an antibody-dr...